 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- ||| HDDO-1756 / Hyundai Pharm
New P1 trial: HDDO-1756 Bio Equivalence Study (clinicaltrials.gov) - Feb 15, 2021
P1, N=56, Completed, Sponsor: Hyundai Pharmaceutical Co., LTD.